Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Repeating Patterns In Human Behavior

GREED AND FEAR The January 1987 edition of Military Review, a professional journal of the U.S. Army, noted: “Since the mind of the individual soldier has not changed and fear is the crucial factor in the outcome of all battles, tactics must be directed not just against...
Chris Ciovacco | December 23, 2019 |

Saudi Arabia Eyes Total Dominance In Oil And Gas

Saudi Arabia's Energy Minister Prince Abdulaziz claimed last week that the Kingdom will be the world's biggest hydrocarbon producer "even" in 2050. "I can assure that Saudi Arabia will not only be the last producer, but Saudi Arabia will produce every molecule of hydrocarb...
Julianne Geiger | July 2, 2020 |

It’s time to dump U.S. Treasury bonds – again

First let’s make sure we understand the basics of bonds. Bonds are a form of debt. When a company or a government needs to borrow money it can borrow from banks and pay interest on the loan, or it can borrow from investors by issuing bonds and paying intere...
Sy Harding | October 28, 2012 |

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New Polaris gold deposit. A one-million-ounce gold deposit that is owned by Canagold Resources ( TSX: CCM ) (OTCBB: CRCUF) ( Frankfurt: CANA), New Polaris may be ...
Marc Davis | September 22, 2021 |

Chinese real estate: Four ways investors can profit

SHANGHAI, The People's Republic of China - Given what you may have heard about Chinese property values in recent months, it may surprise you to learn that Chinese real estate investors are extremely value oriented. And so are the institutional investors I've run i...
Keith Fitz-Gerald | October 28, 2012 |

This Medical Device Company Plans to Grow its Business Through M&A

(Click image to watch video) North America is one of the hottest spots for the medical device industry, having accounted for nearly half of all market revenue in 2019. According to a report , medical devices continue to rise in importance for disease preventio...
Jocelyn Aspa | June 10, 2021 |

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown | May 4, 2023 |
1 2 3 4 5 6 7 8 9 10 ...